Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Boceprevir/PegIFN α-2b/Riba in HCV+ Gt1 Menopausal Women, Nonresponders to PegIFN/Riba or Treatment-naives (MEN_BOC) (MEN_BOC)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT01457937
Recruitment Status : Unknown
Verified September 2012 by Prof. Facchinetti Fabio, University of Modena and Reggio Emilia.
Recruitment status was:  Recruiting
First Posted : October 24, 2011
Last Update Posted : October 2, 2012
Sponsor:
Collaborator:
Merck Sharp & Dohme Corp.
Information provided by (Responsible Party):
Prof. Facchinetti Fabio, University of Modena and Reggio Emilia

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Unknown
Estimated Primary Completion Date : December 2013
Estimated Study Completion Date : June 2014